II
Calendar No. 460
116th CONGRESS
2d Session
H. R. 4739
[Report No. 116–229]
IN THE SENATE OF THE UNITED STATES
December 10, 2019
Received; read twice and referred to the Committee on Homeland Security and Governmental Affairs
June 1, 2020
Reported by Mr. Johnson, with an amendment
Strike out all after the enacting clause and insert the part printed in italic
AN ACT
To amend the Homeland Security Act of 2002 to protect U.S. Customs and Border Protection officers, agents, other personnel, and canines against potential synthetic opioid exposure, and for other purposes.
Short title
This Act may be cited as the Synthetic Opioid Exposure Prevention and Training Act
.
Protection against potential synthetic opioid exposure within U.S. Customs and Border Protection
In general
Subtitle B of title IV of the Homeland Security Act of 2002 (6 U.S.C. 211 et seq.) is amended by inserting after section 415 the following new section:
Protection against potential synthetic opioid exposure
In general
The Commissioner of U.S. Customs and Border Protection shall issue a policy that specifies effective protocols and procedures for the safe handling of potential synthetic opioids, including fentanyl, by U.S. Customs and Border Protection officers, agents, other personnel, and canines, and to reduce the risk of injury or death resulting from accidental exposure and enhance post-exposure management.
Training
In general
Together with the issuance of the policy described in subsection (a), the Commissioner of U.S. Customs and Border Protection shall require mandatory and recurrent training on the following:
The potential risk of opioid exposure and safe handling procedures for potential synthetic opioids, including precautionary measures such as the use of personal protective equipment during such handling.
How to access and administer opioid receptor antagonists, including naloxone, post-exposure to potential synthetic opioids.
Integration
The training described in paragraph (1) may be integrated into existing training under section 411(l) for U.S. Customs and Border Protection officers, agents, and other personnel.
Personal protective equipment and opioid receptor antagonists
Together with the issuance of the policy described in subsection (a), the Commissioner of U.S. Customs and Border Protection shall ensure the availability of personal protective equipment and opioid receptor antagonists, including naloxone, to all U.S. Customs and Border Protection officers, agents, other personnel, and canines at risk of accidental exposure to synthetic opioids.
Oversight
To ensure effectiveness of the policy described in subsection (a)—
the Commissioner of U.S. Customs and Border Protection shall regularly monitor the efficacy of the implementation of such policy and adjust protocols and procedures, as necessary; and
the Inspector General of the Department shall audit compliance with the requirements of this section not less than once each year for the 5 years after the date of the enactment of this section.
.
Clerical amendment
The table of contents in section 1(b) of the Homeland Security Act of 2002 is amended by inserting after the item relating to section 415 the following new item:
Sec. 416. Protection against potential synthetic opioid exposure.
.
Short title
This Act may be cited as the Synthetic Opioid Exposure Prevention and Training Act
.
Protection against potential synthetic opioid exposure within U.S. Customs and Border Protection
In general
Subtitle B of title IV of the Homeland Security Act of 2002 (6 U.S.C. 211 et seq.) is amended by inserting after section 415 the following new section:
Protection against potential synthetic opioid exposure
In general
The Commissioner of U.S. Customs and Border Protection shall issue a policy that specifies effective protocols and procedures for the safe handling of potential synthetic opioids, including fentanyl, by U.S. Customs and Border Protection officers, agents, other personnel, and canines, and to reduce the risk of injury or death resulting from accidental exposure and enhance post-exposure management.
Training
In general
Together with the issuance of the policy described in subsection (a), the Commissioner of U.S. Customs and Border Protection shall require mandatory and recurrent training on the following:
The potential risk of opioid exposure and safe handling procedures for potential synthetic opioids, including precautionary measures such as the use of personal protective equipment during such handling.
How to access and administer opioid receptor antagonists, including naloxone, post-exposure to potential synthetic opioids.
Integration
The training described in paragraph (1) may be integrated into existing training under section 411(l) for U.S. Customs and Border Protection officers, agents, and other personnel.
Personal protective equipment and opioid receptor antagonists
Together with the issuance of the policy described in subsection (a), the Commissioner of U.S. Customs and Border Protection shall ensure the availability of personal protective equipment and opioid receptor antagonists, including naloxone, to all U.S. Customs and Border Protection officers, agents, other personnel, and canines at risk of accidental exposure to synthetic opioids.
Oversight
To ensure effectiveness of the policy described in subsection (a)—
the Commissioner of U.S. Customs and Border Protection shall regularly monitor the efficacy of the implementation of such policy and adjust protocols and procedures, as necessary; and
the Inspector General of the Department shall audit compliance with the requirements of this section not less than once during the 3-year period after the date of the enactment of this section.
.
Clerical amendment
The table of contents in section 1(b) of the Homeland Security Act of 2002 is amended by inserting after the item relating to section 415 the following new item:
Sec. 416. Protection against potential synthetic opioid exposure.
.
June 1, 2020
Reported with an amendment